{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:49:55Z","timestamp":1761763795053},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":7524,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1999]]},"DOI":"10.1254\/jjp.80.209","type":"journal-article","created":{"date-parts":[[2002,8,26]],"date-time":"2002-08-26T16:32:11Z","timestamp":1030379531000},"page":"209-216","source":"Crossref","is-referenced-by-count":19,"title":["A Comparison of the Antagonistic Activities of Tamsulosin and Terazosin Against Human Vascular \u03b11Adrenoceptors"],"prefix":"10.1016","volume":"80","author":[{"given":"Kazuhiro","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Kitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.80.209_bib1","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0022-5347(17)47714-7","article-title":"\u03b1-Adrenoceptors and muscarinic receptors in the isolated human prostate","volume":"134","author":"Hedlund","year":"1985","journal-title":"J Urol"},{"key":"10.1254\/jjp.80.209_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0022-5347(17)47185-0","article-title":"A pharmacological study of \u03b1-adrenergic receptor subtypes in smooth muscles of human urinary bladder base and prostatic urethra","volume":"134","author":"Kunisawa","year":"1985","journal-title":"J Urol"},{"key":"10.1254\/jjp.80.209_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002512-199506030-00005","article-title":"Drug-induced orthostatic hypotension in older patients","volume":"6","author":"Mets","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1254\/jjp.80.209_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1440-1681.1994.tb02534.x","article-title":"Comparative study on \u03b11-adrenoceptor antagonist binding in human prostate and aorta","volume":"21","author":"Yamada","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1254\/jjp.80.209_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0922-4106(95)90161-2","article-title":"\u03b11-Adrenoceptor subtype selectivity of tamsulosin: studies using livers from different species","volume":"289","author":"Garcia-Sainz","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.80.209_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0922-4106(95)90195-7","article-title":"Use of recombinant \u03b11-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy","volume":"288","author":"Foglar","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.80.209_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<55::AID-PROS9>3.0.CO;2-8","article-title":"Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned \u03b11-adrenergic receptor subtypes","volume":"33","author":"Richardson","year":"1997","journal-title":"Prostate"},{"key":"10.1254\/jjp.80.209_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-5347(17)35544-1","article-title":"Identification, quantification, and localization of mRNA for three distinct alpha1-adrenergic receptor subtypes in human prostate","volume":"150","author":"Price","year":"1993","journal-title":"J Urol"},{"key":"10.1254\/jjp.80.209_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00171338","article-title":"\u03b11-Adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy","volume":"348","author":"Michel","year":"1993","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1254\/jjp.80.209_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1474-8673.1996.tb00352.x","article-title":"Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned \u03b11-adrenoceptor subtypes and in human prostate","volume":"16","author":"Michel","year":"1996","journal-title":"J Auton Pharmacol"},{"key":"10.1254\/jjp.80.209_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00231118","article-title":"\u03b11-Adrenoceptors in the human prostatic urethra are different from those of the human peripheral arteries","volume":"72","author":"Takeda","year":"1993","journal-title":"Clin Invest"},{"key":"10.1254\/jjp.80.209_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1994.tb17053.x","article-title":"Pharmacological evidence of distinct \u03b11-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery","volume":"113","author":"Hatano","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.80.209_bib13","first-page":"231","article-title":"Clinical evalutaion of YM617 on bladder outlet obstruction associated with benign prostatic hypertrophy. A double-blind, multi-center study compared with placebo","volume":"4","author":"Kawabe","year":"1991","journal-title":"Jpn J Urol Surg"},{"key":"10.1254\/jjp.80.209_bib14","first-page":"823","article-title":"Clinical evaluation of terazosin hydrochloride on urinary obstruction caused by benign prostatic hypertrophy (II). Double-blind comparative study compared with placebo","volume":"5","author":"Kumamoto","year":"1992","journal-title":"Jpn J Urol Surg"},{"key":"10.1254\/jjp.80.209_bib15","first-page":"33","article-title":"Benign prostatic hyperplasia: use of drug therapy in primary care","volume":"53","author":"Beduschi","year":"1998","journal-title":"Geriatrics"},{"key":"10.1254\/jjp.80.209_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1464-410X.1997.00411.x","article-title":"Clinical comparison of selective and non-selective \u03b11A-adrenoceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses","volume":"80","author":"Lee","year":"1997","journal-title":"Br J Urol"},{"key":"10.1254\/jjp.80.209_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.1988.tb05276.x","article-title":"The effect of prazosin on skin microcirculation as assessed by laser Doppler flowmetry","volume":"26","author":"Khan","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1254\/jjp.80.209_bib18","first-page":"371","article-title":"Effect of \u03b11-adrenoceptor antagonists, prazosin and urapidil, on a finger skin vasoconstrictor response to cold stimulation","volume":"46","author":"Harada","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1254\/jjp.80.209_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.1981.tb00527.x","article-title":"A new technique for recording compliance of human hand veins","volume":"11","author":"Aellig","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1254\/jjp.80.209_bib20","first-page":"2529","article-title":"Phase I clinical trial of YM617, a new \u03b11-adrenoceptor antagonist. Second report: A single oral dose of controlled release formulation in healthy male subjects","volume":"6","author":"Tsunoo","year":"1990","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.80.209_bib21","first-page":"667","article-title":"Pharmacokinetics and pharmacological actions of terazosin hydrochloride, a new \u03b11-blocker (NO. 1). A single dose study on Japanese healthy subjects","volume":"3","author":"Ebihara","year":"1987","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.80.209_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2125.1987.tb03085.x","article-title":"A pragmatic approach to the pressor dose-responses as an index of vascular reactivity and adrenoceptor function in man","volume":"23","author":"Sumner","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1254\/jjp.80.209_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/cs0690215","article-title":"The effect of adrenaline upon cardiovascular and metabolic functions in man","volume":"69","author":"Fellows","year":"1985","journal-title":"Clin Sci"},{"key":"10.1254\/jjp.80.209_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1748-1716.1986.tb07969.x","article-title":"Alpha-adrenoceptors in the vessels of human figer skin","volume":"128","author":"Lindblad","year":"1986","journal-title":"Acta Physiol Scand"},{"key":"10.1254\/jjp.80.209_bib25","first-page":"409","article-title":"Laser doppler flowmetry, a reliable technique for measuring pharmacologically induced changes in cutaneous blood flow?","volume":"9","author":"M\u00fcller","year":"1987","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1254\/jjp.80.209_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/clpt.1985.214","article-title":"Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity","volume":"38","author":"Alradi","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1254\/jjp.80.209_bib27","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/bmj.1.6075.1507","article-title":"Influence of dosage and dietary sodium on the first-dose effects of prazosin","volume":"1","author":"Stokes","year":"1977","journal-title":"BMJ"},{"key":"10.1254\/jjp.80.209_bib28","first-page":"240","article-title":"Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs and humans","volume":"26","author":"Matsushima","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1254\/jjp.80.209_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9343(86)90847-8","article-title":"Pharmacokinetics of terazosin","volume":"80","author":"Sonders","year":"1986","journal-title":"Am J Med"},{"key":"10.1254\/jjp.80.209_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1254\/jjp.78.331","article-title":"Tamsulosin: \u03b11-Adrenoceptor subtype-selectivity and comparison with terazosin","volume":"78","author":"Muramatsu","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.80.209_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1113\/jphysiol.1977.sp012051","article-title":"Postural effects on muscle nerve sympathetic activity in man","volume":"272","author":"Burke","year":"1997","journal-title":"J Physiol (Lond)"},{"key":"10.1254\/jjp.80.209_bib32","series-title":"Handbook of Physiology, Section 2, The Cardiovascular System, Vol III, Peripheral Circulation and Organ Blood Flow","first-page":"427","article-title":"Physiology of the capacitance vessels","author":"Rothe","year":"1983"},{"key":"10.1254\/jjp.80.209_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archfami.2.9.929","article-title":"Terazosin in the treatment of benign prostatic hyperplasia","volume":"2","author":"Brawer","year":"1993","journal-title":"Arch Fam Med"},{"key":"10.1254\/jjp.80.209_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia","volume":"335","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1254\/jjp.80.209_bib35","first-page":"155","article-title":"Tamsulosin, the first prostate-selective \u03b11A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled multicentre studies in patients with benign prostatic obstruction (symptomatic BPH)","volume":"29","author":"Chappie","year":"1996","journal-title":"Eur Urol"},{"key":"10.1254\/jjp.80.209_bib36","first-page":"209","volume":"49","author":"Ford","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.80.209_bib37","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjp.0701207","article-title":"Pharmacological pleiotropism of the human recombinant \u03b11A-adrenoceptor: implications for \u03b11-adrenoceptor classification","volume":"121","author":"Ford","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.80.209_bib38","first-page":"63","article-title":"Phase I clinical trial of YM617, a new \u03b11-adrenoceptor antagonist. Third report: Multiple oral doses of controlled release formulation in healthy male subjects","volume":"7","author":"Tsunoo","year":"1991","journal-title":"J Clin Ther Med"},{"key":"10.1254\/jjp.80.209_bib39","first-page":"681","article-title":"Pharmacokinetics and pharmacological actions of terazosin hydrochloride, a new \u03b11-blocker (NO. 2). A multiple dose study on Japanese healthy subjects","volume":"3","author":"Ebihara","year":"1987","journal-title":"J Clin Ther Med"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819308443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819308443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jjp\/80\/3\/80_3_209\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:21:26Z","timestamp":1605637286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819308443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999]]}},"alternative-id":["S0021519819308443"],"URL":"https:\/\/doi.org\/10.1254\/jjp.80.209","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1999]]}}}